Understand the source comparison
Best Peptides for Lyme Disease: Research Comparison
Thymalin T-cell maturation, Treg restoration Immune dysregulation, T-cell exhaustion Clinical use in Russia/Eastern Europe; limited Western trials 10mg SubQ every 48 hours × 10 doses Strongest immunomodulatory data for post-infectious immune collapse BPC-157 V
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- T-cell maturation, Treg restoration
- Immune dysregulation, T-cell exhaustion
- Clinical use in Russia/Eastern Europe; limited Western trials
- 10mg SubQ every 48 hours × 10 doses
- Strongest immunomodulatory data for post-infectious immune collapse
- BPC-157
- VEGF/FGF-2 modulation, mitochondrial repair
- Tissue damage, neuroborreliosis, gut permeability
- Extensive rodent data; human case reports
- 250–500 mcg SubQ daily
- Most versatile—addresses multiple Lyme sequelae simultaneously
- KPV
- NF-κB inhibition, local anti-inflammatory
- Persistent cytokine elevation, gut inflammation
- Phase 2 ulcerative colitis trials ongoing
- 500 mcg oral or 200 mcg SubQ daily
- Best for gut-dominant symptoms and systemic inflammation
- Cerebrolysin
- Neurotrophic factor delivery, BDNF/NGF signaling
- Cognitive dysfunction, neuroprotection
- Approved in EU/Asia; 200+ clinical trials in stroke/dementia
- 5–10 mL IV daily × 20 sessions
- Gold standard for neuroborreliosis-associated cognitive decline
- Dihexa
- HGF receptor activation, synaptogenesis
- Memory deficits, synaptic loss
- Preclinical only; potent in animal models
- 1–5 mg/kg in rodent studies (human dosing undefined)
- Promising but early-stage; wait for human safety data
- MK-677
- GH/IGF-1 secretagogue
- Anabolic recovery, immune cell proliferation
- Human trials in sarcopenia/aging; well-tolerated
- 25 mg oral daily
- Useful adjunct for overall recovery acceleration, not Lyme-specific